Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Unicycive Therapeutics, Inc. | Director | Stock Options | 124K | Sep 5, 2023 | Direct | ||
Kadmon Holdings, Inc. | EVP, Chief Medical Officer | Equity Appreciation Rights Unit | 0 | $3.50 | Nov 9, 2021 | Direct | |
Kadmon Holdings, Inc. | EVP, Chief Medical Officer | Stock Option (right to buy) | 0 | $5.54 | Nov 9, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
UNCY | Unicycive Therapeutics, Inc. | Sep 5, 2023 | 1 | $0 | 4 | Sep 7, 2023 | Director |
KDMN | Kadmon Holdings, Inc. | Nov 9, 2021 | 6 | -$3.2M | 4 | Nov 9, 2021 | EVP, Chief Medical Officer |
UNCY | Unicycive Therapeutics, Inc. | Jul 12, 2021 | 0 | $0 | 3 | Jul 12, 2021 | Director |